Film subsidy receipts and directors' medical reimbursement: subsidy was non-taxable, and partial disallowance of expenses failed.

A receipt linked to a government film subsidy scheme was treated as a subsidy or grant tied to film quality and success, not as trading income, because it was not shown to be expected as a return for labour, skill or capital; it was therefore not taxable. Medical expenses reimbursed for a managing director's treatment in the U.S.A. were accepted as commercially expedient and actually incurred, so no rational basis remained for a partial disallowance under the director-benefit restriction; the full expenditure was allowable. The reference was answered entirely in favour of the assessee.

---

---

Issues: (i) Whether the amount recovered from exhibitors as entertainment duty formed part of the assessee's income or was a casual and non-recurring receipt exempt from tax; (ii) whether the medical expenses incurred for the managing director's treatment in the U.S.A. could be partly disallowed under section 10(4A).

Issue (i): Whether the amount recovered from exhibitors as entertainment duty formed part of the assessee's income or was a casual and non-recurring receipt exempt from tax.

Analysis: The amount was received pursuant to a government scheme intended to reward and subsidise high-quality films, but it was not shown that the assessee produced the film with any expectation of such payment. A receipt does not become income merely because it has a source or is connected with a business; it must bear the character of a return for labour, skill or capital and not be a windfall in its very nature. The payment in question was treated as a subsidy or grant tied to the success and quality of the film, not as trading receipt from ordinary film business.

Conclusion: The amount did not constitute income of the assessee and was not taxable.

Issue (ii): Whether the medical expenses incurred for the managing director's treatment in the U.S.A. could be partly disallowed under section 10(4A).

Analysis: The Tribunal had accepted that the company reimbursed the expenditure on the footing of commercial expediency and that the expenses were actually incurred and not shown to be excessive or unproved. Once the entire reimbursement was found to be justified on that basis, there was no rational basis for treating only one-third of the expenditure as inadmissible under the statutory restriction on benefits or amenities to directors. The statutory bar could not logically apply in part while allowing the rest on the same facts.

Conclusion: The entire medical expenditure was allowable and the partial disallowance was not sustainable.

Final Conclusion: The reference was answered entirely in favour of the assessee on both questions, and no part of the disputed additions or disallowances survived.

Ratio Decidendi: A receipt is taxable as income only if it has the character of a return from a definite source for labour, skill or capital and is not a mere windfall in its very nature, and where an expenditure is accepted as commercially expedient and fully proved, it cannot be arbitrarily disallowed in part under a provision aimed at prohibiting benefit or amenity payments to directors.

---